Proton pump inhibitors for dyspepsia.

Area of Science:

• Gastroenterology
• Primary Care Medicine

Background:

• Dyspepsia is a prevalent condition managed in primary care settings.
• Endoscopic evaluation is often impractical and unaffordable for many dyspepsia patients.
• Helicobacter pylori eradication is effective but declining prevalence necessitates alternative strategies.

Purpose of the Study:

• To evaluate proton pump inhibitor (PPI) therapy as an alternative management strategy for dyspepsia.
• To assess the cost-effectiveness of acid suppression compared to other dyspepsia treatments.

Main Methods:

• Review of current dyspepsia management guidelines.
• Analysis of cost-effectiveness studies comparing PPI therapy, endoscopy, and H. pylori eradication.
• Consideration of H. pylori prevalence in Western countries.

Main Results:

• Proton pump inhibitor therapy is incorporated into international dyspepsia management guidelines (USA, UK, Canada).
• Acid suppression alone is more cost-effective than endoscopy or H. pylori testing and treatment in young patients in low H. pylori prevalence regions.

Conclusions:

• Proton pump inhibitors represent a viable and cost-effective approach for dyspepsia management.
• Acid suppression strategies are increasingly important given the declining prevalence of H. pylori infection.